Search Back New search Go to resultsDiseaseMain groupSolid TumorsProtocol groupGastroenterologic OncologyGynecological OncologyThoracic TumorsTumor, regardless of entityDiseaseBreast CancerLung Carcinoma, Non-Small CellLung Carcinoma, Small CellTumor, Various OrgansSubgroupICD10C34.-C50.-MeSHBreast NeoplasmsCarcinoma, Non-Small-Cell LungSmall Cell Lung CarcinomaSequenceChemotherapyChemo-substanceCisplatinChemo-substanceCisplatinChemo-substanceCisplatinChemo-substanceCisplatinNo. Substances1 RadiotherapySupportive therapySupportive substanceSupportive substanceSupportive substanceSupportive substanceNo. SubstancesProtocol classificationTherapy classificationalternativeIntensityStandard doseTherapy indicationseveral possibleTherapy phaseTherapy intentionpalliativeRisksCardiotoxicityEmetogenicity only studiesPublicationAuthorMaisch BDiseaseMaligner Perikarderguss, hämodynamisch relevantOriginDepartment of Internal Medicine-Cardiology, Philipps University, Marburg, GermanyProtocols in Revision 1 protocol foundProtocols under revision.Cisplatin 30, Tumor, Various Organs (PID2371)